Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Abstract:
The investment was made by a syndicate of investors, including existing investor Mercia Technology Seed Fund, Advantage Enterprise & Innovation Fund (managed by Catapult Venture Managers) and a number of business angels.

Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Cambridge, UK | Posted on May 30th, 2011

Corporate finance solicitor Pippa Pearce led the Mills & Reeve team representing the highly innovative life sciences company, which develops and commercialises innovative magnetic nanoparticle based products in the gene therapy research market.

nanoTherics was spun out from Keele University in 2007 following 30 years of combined leading edge research into the use of magnetic nanoparticles for biomedical applications conducted at Keele University and the University of Florida.

The company provides unique scientific devices and associated reagents designed to significantly improve uptake of biomaterials into cells, a process referred to as transfection, to greatly facilitate research into gene-related diseases and disorders. The company's mission is to become the leading supplier of intellectual property protected magnetic nanoparticle-based devices and consumables for transfection, providing superior performance products addressing a global market and underpinning the research and development of current and future drug and genetic screening and gene therapy programmes.

The investment took place on two tranches, with the first tranche completing in August 2010 and the second in January 2011. Dr Linda Cammish, CEO of nanoTherics said: "The funding has come at the appropriate time to allow nanoTherics to further develop its innovative technologies and products and improve research into genetic disease disorders, from Alzheimer's to cancer. This investment represents a critical point in the company's growth strategy and will enable us to place additional resources into the commercialism of our products."

Dr Mark Payton, Fund Principal at Mercia added: "We're delighted to continue to support nanoTherics in the development of its scalable and disruptive products and look forward to the next exciting step in the company's growth plan." He went on to say: "Mills & Reeve's venture capital team provided vital support in helping us complete this round - their experience and expertise in advising on sometimes complex syndicated investments in early stage and developing high-tech businesses was invaluable."

Pippa Pearce was assisted on the transaction by corporate lawyers, Dona Ardeman and Danielle Gibson and technology solicitor Nicola Kenward. Pippa commented: "We are pleased to have been able to assist this ambitious technology company raise the finance needed to ramp up commercialisation of its exciting products. We will follow their progress with interest."

Advantage Enterprise & Innovation Fund were advised by West Midlands firm George Green, led by partner Guy Green and assisted by Philip Round.

####

About Cambridge Network
With offices located in Cambridge, Norwich, Birmingham, Leeds, Manchester and London, Mills & Reeve is one of the UK's largest law firms, offering the full range of corporate and commercial services.

Our Cambridge office includes a specialist IP team dedicated to advising the region's technology companies and we have a close working relationship with Trask Britt, a specialist intellectual property firm based in the US.

We have over 80 qualified lawyers operating from our Norwich and Cambridge offices; with 23 partners leading teams in commercial, tax, banking, corporate finance, pensions, disputes and regulatory matters, with a specific focus on technology-based companies, advising on IP/IT, environmental, health and safety and related property issues.

We were also selected as one of the top three firms by The Lawyer magazine's prestigious 'Law Firm of the Year Award', Mills & Reeve was listed in the Sunday Times '100 Best Companies to Work For' for the seventh year running.

For more information, please click here

Contacts:
Francis House, 112 Hills Road, Cambridge
Postcode: CB2 1PH
United Kingdom
Tel: 44 01223 364422
Fax: 44 01223 355848

www.mills-reeve.com/

Copyright © Cambridge Network

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project